Stroke prevention: an update (Q37998367)

26 August 2017

Stroke prevention: an update (English)

1 reference

26 August 2017

Marie-Germaine Bousser

series ordinal

1

object named as

Marie-Germaine Bousser

0 references

publication date

31 March 2012

1 reference

26 August 2017

Frontiers of medicine

1 reference

26 August 2017

6

1 reference

26 August 2017

22-34

1 reference

26 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11684-012-0178-6

26 August 2017

0 references

cites work

Preventing stroke: saving lives around the world.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Global variation in the relative burden of stroke and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

A strategy to reduce cardiovascular disease by more than 80%

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

The impact of prevention on reducing the burden of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

The 2006 William Feinberg lecture: shifting the paradigm from stroke to global vascular risk estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Smoking and smoking cessation in relation to mortality in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Alcohol consumption and risk of stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Alcohol consumption and risk for stroke among Chinese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Fruit and vegetable intake in relation to risk of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Fruit and vegetable consumption and stroke: meta-analysis of cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Projected effect of dietary salt reductions on future cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Physical activity and stroke risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Body Mass Index, Waist Circumference, and Waist-Hip Ratio on the Risk of Total and Type-Specific Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Body mass index and risk of stroke among Chinese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Epidemic increase in overweight and obesity in Chinese children from 1985 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Primary prevention of stroke by healthy lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised con

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Healthy lifestyle and the risk of stroke in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Combined effect of health behaviours and risk of first ever stroke in 20,040 men and women over 11 years' follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Blood pressure and stroke: an overview of published reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Long-term effects of intensive glucose lowering on cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Efficacy of folic acid supplementation in stroke prevention: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Air pollution as an emerging global risk factor for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Cumulative effects of weather on stroke incidence: a multi-community cohort study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Low pessimism protects against stroke: the Health and Social Support (HeSSup) prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Green and black tea consumption and risk of stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Cocoa and cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Antithrombotic agents in the prevention of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Genetic determinants of response to clopidogrel and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Contemporary results of carotid endarterectomy for asymptomatic carotid stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Carotid Artery Stenting vs Carotid Endarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Stenting versus endarterectomy for treatment of carotid-artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Intracranial atherosclerotic disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Intracranial atherosclerosis: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Medication adherence in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Probability of stroke: a risk profile from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Triflusal for Preventing Serious Vascular Events in People at High Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Stemming the global tsunami of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0178-6

Lower socioeconomic status and increased mortality: early childhood roots and the potential for successful interventions

21 January 2018

1 reference

12 December 2020

Global burden of hypertension: analysis of worldwide data

1 reference

12 December 2020

What is the current status of invasive treatment of extracranial carotid artery disease?

1 reference

12 December 2020

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

12 December 2020

Organised inpatient (stroke unit) care for stroke

1 reference

12 December 2020

Cilostazol: a drug particularly effective for Asians?

1 reference

12 December 2020

Reducing the global burden of ischemic heart disease and stroke: a challenge for the cardiovascular community and the United Nations

1 reference

12 December 2020

Potential societal savings from reduced sodium consumption in the U.S. adult population

1 reference

12 December 2020

Antihypertensive therapy for prehypertension: relationship with cardiovascular outcomes

1 reference

12 December 2020

Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin

1 reference

12 December 2020

Thrombolytic therapy with alteplase for ischaemic stroke

1 reference

12 December 2020

Reduced dietary salt for the prevention of cardiovascular disease

1 reference

12 December 2020

The perils of combination antithrombotic therapy and potential resolutions

1 reference

12 December 2020

Stroke prevention: the need for a global response

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

10.1007/S11684-012-0178-6

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22460445